ProPhase Labs PRPH
OTC PRPH
$0.01 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

ProPhase Labs (PRPH) EV to EBITDA (2013 - 2023)

Updated

ProPhase Labs' EV to EBITDA was 8.82 in Q1 2023, up 219.8% from 2.76 a year earlier and up 80.0% from the prior quarter.

Analysis

ProPhase Labs (PRPH) EV to EBITDA (2013 - 2023) Analysis & Trends

On a trailing twelve-month basis, ProPhase Labs' EV to EBITDA was 3.36 through Mar 31, 2023; for FY2022, it came in at 4.90, down 32.0% from FY2021.

  • In earlier years, EV to EBITDA was 7.20 in FY2021.
  • The Q1 2023 figure marks the highest quarterly EV to EBITDA since Q1 2021.
  • Per Business Quant data, PRPH's EV to EBITDA in the three quarters before Q1 2023 was 4.90 (Q4 2022), 3.32 (Q3 2022) and 4.24 (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 ProPhase Labs 155,925.56 -390,074.44 226,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 8.80
Dec 31, 2022 4.90
Sep 30, 2022 3.32
Jun 30, 2022 4.24
Mar 31, 2022 2.76
Dec 31, 2021 7.20
Mar 31, 2021 88.55
Dec 31, 2013 38.22
Sep 30, 2013 58.05
Jun 30, 2013 58.64
Mar 31, 2013 157.75
API Access

ProPhase Labs EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=PRPH&period=max&api_key=YOUR_API_KEY